SoVote

Decentralized Democracy

House Hansard - 38

44th Parl. 1st Sess.
March 1, 2022 10:00AM
Context: House Hansard - 38 - Mar/1/22
Ms. Emmanuella Lambropoulos (Saint-Laurent, Lib.)
  • Mar/1/22 3:01:58 p.m.
  • Watch
Mr. Speaker, the last two years of this pandemic have underscored the importance of investing in domestic manufacturing of vaccines and personal protective equipment and, therefore, supporting science and research in Canada. It is also important to provide Canadians with options, which is why I am pleased to rise in the House today to ask about the first Canadian-made, plant-based COVID-19 vaccine, the Medicago vaccine, which was approved by Health Canada on February 24. Can the Minister of Health outline how the government is supporting the use of this vaccine?
95 words
All Topics
  • Hear!
  • Rabble!
  • star_border
Context: House Hansard - 38 - Mar/1/22
Hon. Jean-Yves Duclos (Minister of Health, Lib.)
  • Mar/1/22 3:02:35 p.m.
  • Watch
Mr. Speaker, I thank the hon. member for Saint-Laurent for her excellent question and her excellent work. Last Thursday, Medicago's Covifenz vaccine was approved by Health Canada. It is the first Canadian vaccine approved by Health Canada. It is also the first approved vaccine in the world to use plant-based technologies. The work of Medicago's workers and partners is giving Canadians one more tool to protect their health and safety. It is good news all around.
81 words
All Topics
  • Hear!
  • Rabble!
  • star_border